{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:49:38Z","timestamp":1779306578547,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ensci.2020.100243","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:06:13Z","timestamp":1589681173000},"page":"100243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients"],"prefix":"10.1016","volume":"19","author":[{"given":"Alessia","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Aurelia","family":"Banco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Realmuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Vazzoler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Portera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"La Tona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ensci.2020.100243_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/CMR.5.1.49","article-title":"Pathogenesis and molecular biology of progressive multifocal Leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain","volume":"5","author":"Major","year":"1992","journal-title":"Clin. Microbiol. Rev."},{"issue":"Suppl2","key":"10.1016\/j.ensci.2020.100243_bb0010","first-page":"S98","article-title":"Progressive multifocal Leukoencephalopathy: JC virus induced demyelination in the immune compromised host","volume":"6","author":"Hou","year":"2000","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ensci.2020.100243_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.20933","article-title":"Progressive multifocal Leukoencephalopathy revisited: has the disease outgrown its name?","volume":"60","author":"Koralnik","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.ensci.2020.100243_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4161\/mabs.1.6.9884","article-title":"Monoclonal antibodies and progressive multifocal Leukoencephalopathy","volume":"1","author":"Berger","year":"2009","journal-title":"mAb"},{"issue":"4","key":"10.1016\/j.ensci.2020.100243_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal Leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ensci.2020.100243_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2010.09.021","article-title":"Progressive multifocal Leukoencephalopathy","volume":"231","author":"Weissert","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.ensci.2020.100243_bb0035","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3174\/ajnr.A2035","article-title":"JC virus infection of the brain","volume":"31","author":"Bag","year":"2010","journal-title":"Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.ensci.2020.100243_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12948","article-title":"Progressive multifocal Leucoencephalopathy \u2013 driven from rarity to clinical mainstream by iatrogenic immunodeficiency","volume":"188","author":"Misbah","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.ensci.2020.100243_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal Leukoencephalopathy in individuals with minimal or occult immunosuppression","volume":"81","author":"Gheuens","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.ensci.2020.100243_bb0050","first-page":"137","article-title":"Immune surveillance and response to JC virus infection and PML","volume":"20","author":"Beltrami","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"Suppl1","key":"10.1016\/j.ensci.2020.100243_bb0055","first-page":"25","article-title":"Inflammatory reaction in progressive multifocal Leukoencephalopathy: harmful or beneficial?","volume":"9","author":"Du Pasquier","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ensci.2020.100243_bb0060","series-title":"L\u2019uso dei Farmaci in Italia. Rapporto Nazionale","author":"Agenzia Italiana del Farmaco","year":"2016"},{"issue":"1","key":"10.1016\/j.ensci.2020.100243_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/cid\/ciy030","article-title":"Diagnostic and prognostic value of JC virus DNA in plasma in progressive multifocal Leukoencephalopathy","volume":"67","author":"Ferretti","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ensci.2020.100243_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10072-009-0149-0","article-title":"Progressive necrotic encephalopathy following Tacrolimus therapy for liver transplantation","volume":"30","author":"Aridon","year":"2009","journal-title":"Neurol. Sci."},{"issue":"15","key":"10.1016\/j.ensci.2020.100243_bb0075","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"Progressive multifocal Leukoencephalopathy diagnostic criteria: consensus statement from the AAN Neuroinfectious disease section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurol"},{"issue":"6","key":"10.1016\/j.ensci.2020.100243_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crad.2010.03.001","article-title":"Imaging manifestations of progressive multifocal Leukoencephalopathy","volume":"65","author":"Shah","year":"2010","journal-title":"Clin. Radiol."},{"issue":"5","key":"10.1016\/j.ensci.2020.100243_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"Magnetic resonance imaging pattern in Natalizumab-associated progressive multifocal Leukoencephalopathy","volume":"72","author":"Yousry","year":"2012","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ensci.2020.100243_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neurad.2011.12.005","article-title":"Gadolinium enhancement in brain magnetic resonance imaging in progressive multifocal Leukoencephalopathy after Natalizumab monotherapy: is it really atypical?","volume":"39","author":"Arnaud","year":"2012","journal-title":"J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.ensci.2020.100243_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1148\/radiology.187.1.8451420","article-title":"Progressive multifocal Leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation","volume":"187","author":"Whiteman","year":"1993","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.ensci.2020.100243_bb0100","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1468-1331.2006.01362.x","article-title":"Progressive multifocal Leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control","volume":"13","author":"K\u00fcker","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.ensci.2020.100243_bb0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00234-003-0966-4","article-title":"Progressive multifocal Leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI","volume":"45","author":"Mader","year":"2003","journal-title":"Neuroradiology"},{"issue":"5","key":"10.1016\/j.ensci.2020.100243_bb0110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00330-007-0845-1","article-title":"Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy","volume":"18","author":"Cosottini","year":"2008","journal-title":"Eur. Radiol."},{"issue":"161","key":"10.1016\/j.ensci.2020.100243_bb0115","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2214\/ajr.161.5.8273607","article-title":"Progressive multifocal Leukoencephalopathy: contrast enhancement on CT scans and MR images","volume":"5","author":"Wheeler","year":"1993","journal-title":"Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.ensci.2020.100243_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcv.2008.07.003","article-title":"False negative PCR despite high levels of JC virus DNA in spinal fluid: implications for diagnostic testing","volume":"43","author":"Landry","year":"2008","journal-title":"J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.ensci.2020.100243_bb0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.clineuro.2012.08.013","article-title":"JCV-negative Natalizumab-associated progressive multifocal Leukoencephalophaty: a Clinico-radiological","volume":"115","author":"Travasarou","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.ensci.2020.100243_bb0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/00207454.2012.760561","article-title":"A case of Natalizumab-associated progressive multifocal Leukoencephalopathy with repeated negative CSF JCV testing","volume":"123","author":"Mazda","year":"2013","journal-title":"Int. J. Neurosci."},{"issue":"3","key":"10.1016\/j.ensci.2020.100243_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.410440309","article-title":"Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal Leukoencephalopathy","volume":"44","author":"Berger","year":"1998","journal-title":"Ann. Neurol."},{"issue":"19","key":"10.1016\/j.ensci.2020.100243_bb0140","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.0b013e3181c0d4a1","article-title":"Determinants of survival in progressive multifocal Leukoencephalopathy","volume":"73","author":"Marzocchetti","year":"2009","journal-title":"Neurol"},{"issue":"11","key":"10.1016\/j.ensci.2020.100243_bb0145","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in Natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ensci.2020.100243_bb0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal Leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.ensci.2020.100243_bb0155","first-page":"702","article-title":"JCV virology, progressive multifocal Leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment","volume":"21","author":"Patera","year":"2015","journal-title":"J. Neuro-Oncol."},{"issue":"5700","key":"10.1016\/j.ensci.2020.100243_bb0160","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"Elphick","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ensci.2020.100243_bb0165","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40261-016-0433-8","article-title":"Treatment of progressive multifocal Leukoencephalopathy with mirtazapine","volume":"36","author":"Jamilloux","year":"2016","journal-title":"Clin. Drug Investig."},{"issue":"4","key":"10.1016\/j.ensci.2020.100243_bb0170","first-page":"351","article-title":"A study of Mefloquine treatment for progressive multifocal Leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J. Neuro-Oncol."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650220300228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650220300228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:17:53Z","timestamp":1762503473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650220300228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"alternative-id":["S2405650220300228"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2020.100243","relation":{},"ISSN":["2405-6502"],"issn-type":[{"value":"2405-6502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2020.100243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100243"}}